Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3762 3775 3792 3796 3797
This examiner grants 70% of resolved cases
George Robert Evanisko is an examiner in Tech Center 3700 and Art Unit 3762, with 938 resolved cases. The allowance rate is 70.4 percent, suggesting a generally favorable environment for applicants and a high probability of a grant. The median days to allowance is 1113, which is a standard duration for this unit and provides a clear timeline for prosecution.
The interview lift is a substantial 34.9 percent, indicating that interviews are highly effective in moving cases toward allowance. This lift suggests that verbal advocacy can significantly improve the 70.4 percent baseline for the 938 resolved cases. Practitioners should use the 1113-day median pendency as a guide for their prosecution strategy and prioritize interviews to leverage the 34.9 percent lift. The combination of a 70.4 percent allowance rate and a 34.9 percent lift makes this a very active and responsive profile for applicants.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18901858 | Passive Charge Recovery Circuitry for an Implantable Medical Device | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18946059 | SYSTEM AND METHOD FOR DETECTION AND MAPPING OF NEAR FIELD CONDUCTION IN SCAR TISSUE | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 18694373 | INTRAVASCULAR BALLOON REPERFUSION THERAPY DEVICES, SYSTEMS, AND METHODS | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18833852 | Systems and Methods for Randomized Coordinated Reset Deep Brain Stimulation | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18470721 | IMPLANTABLE STIMULATOR WITH EXTERNALIZED BATTERY | Non-Final OA | Medtronic, Inc. |
| 18358578 | IMPLANTABLE MEDICAL DEVICE USING INTERNAL SENSORS TO DETERMINE WHEN TO SWITCH OPERATIONAL MODES | Non-Final OA | Medtronic, Inc. |
| 17361707 | MAPPING EFFICIENCY BY SUGGESTING MAP POINT'S LOCATION | Final Rejection | Biosense Webster (Israel) Ltd. |
| 18728579 | IMPLANTABLE STIMULATION ARRANGEMENT STRUCTURES | Final Rejection | Cochlear Limited |
| 18044905 | PARAMETER OPTIMIZATION BASED ON DIFFERENT DEGREES OF FOCUSING | Non-Final OA | Cochlear Limited |
| 18001837 | MEDICAL DEVICE CONTROL WITH VERIFICATION BYPASS | Final Rejection | Cochlear Limited |
| 19058919 | BIOLOGICAL INFORMATION MEASURING DEVICE | Non-Final OA | OMRON HEALTHCARE Co., Ltd. |
| 18118121 | SYSTEM AND METHOD TO MANAGING STIMULATION OF SELECT A-BETA FIBER COMPONENTS | Final Rejection | Pacesetter, Inc. |
| 17711735 | METHODS AND SYSTEMS FOR ANALYZING ELECTROCARDIOGRAM (ECG) SIGNALS | Non-Final OA | Pacesetter, Inc. |
| 18495503 | ELECTRODE LEADS HAVING MULTI-APPLICATION HELICAL NERVE CUFFS AND ASSOCIATED SYSTEMS AND METHODS | Final Rejection | The Alfred E. Mann Foundation for Scientific Research |
| 18180591 | VAGUS NERVE STIMULATION PUPILLOMETRY FOR ELECTRODE SELECTION AND TITRATION | Final Rejection | The Alfred E. Mann Foundation for Scientific Research |
| 18178362 | WEARABLE MEDICAL SYSTEM (WMS) IMPLEMENTING WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) AND RECORDING ECG OF PATIENT IN REGULAR MODE AND IN RICH MODE | Non-Final OA | West Affum Holdings DAC |
| 18333906 | SYSTEMS AND METHODS FOR INCREASING INTESTINAL ABSORPTION OF THERAPEUTIC AGENTS | Non-Final OA | Novocure GmbH |
| 17778319 | IMPLANTABLE ARRAYS FOR PROVIDING TUMOR TREATING FIELDS | Non-Final OA | NOVOCURE GMBH |
| 18102800 | SENSING ELECTRODE AND METHOD OF FABRICATING THE SAME | Non-Final OA | Ramot at Tel-Aviv University Ltd. |
| 18161641 | SIX LEAD ECG DEVICE WITH A REDUCED FORM FACTOR | Final Rejection | AliveCor, Inc. |
| 18694219 | IMPLANTABLE CRANIAL ELECTRONICS | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18678686 | DIAGNOSTIC SYSTEMS AND METHODS FOR USE DURING A PROCEDURE ASSOCIATED WITH A COCHLEAR IMPLANT | Final Rejection | Advanced Bionics AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy